Angiogenesis revisited from a metabolic perspective: role and therapeutic implications of endothelial cell metabolism
Endothelial cell (EC) metabolism has lately emerged as a novel and promising therapeutic target to block vascular dysregulation associated with diseases like cancer and blinding eye disease. Glycolysis, fatty acid oxidation (FAO) and, more recently, glutamine/asparagine metabolism emerged as key reg...
Main Authors: | Nihed Draoui, Pauline de Zeeuw, Peter Carmeliet |
---|---|
Format: | Article |
Language: | English |
Published: |
The Royal Society
2017-01-01
|
Series: | Open Biology |
Subjects: | |
Online Access: | https://royalsocietypublishing.org/doi/pdf/10.1098/rsob.170219 |
Similar Items
-
PFKFB3: A Potential Key to Ocular Angiogenesis
by: Zi-Yi Zhou, et al.
Published: (2021-03-01) -
The PFKFB3 Inhibitor AZ67 Inhibits Angiogenesis Independently of Glycolysis Inhibition
by: Besa Emini Veseli, et al.
Published: (2021-05-01) -
MALAT1 sponges miR-26a and miR-26b to regulate endothelial cell angiogenesis via PFKFB3-driven glycolysis in early-onset preeclampsia
by: Qi Li, et al.
Published: (2021-03-01) -
Endothelial Cell Glucose Metabolism and Angiogenesis
by: Wa Du, et al.
Published: (2021-02-01) -
Metabolic regulation of exercise-induced angiogenesis
by: Tatiane Gorski, et al.
Published: (2019-04-01)